These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13754119)

  • 1. [Colposcopic, cytological and histological studies on the portio uteri under Endoxan treatment].
    KRAUSSOLD E; WENIG H
    Munch Med Wochenschr; 1960 Nov; 102():2410-1. PubMed ID: 13754119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local cytostatic treatment of carcinoma in situ of the cervix uteri. (Report on 6 further observations)].
    HILLEMANNS HG; WAGNER D
    Strahlentherapie; 1962 Mar; 117():417-31. PubMed ID: 13907431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Upon the beginning of a new epoch in the treatment of carcinoma of the cervix].
    KNAUS HH
    Wien Klin Wochenschr; 1961 Sep; 73():561-5. PubMed ID: 13757068
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative colposcopic, cytological and histological studies of the uterine cervix during pregnancy].
    Scharnke HD; Jorde A; Peschel HG; Sielaff E
    Zentralbl Gynakol; 1976; 98(25):1547-52. PubMed ID: 1020511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogastric arteriography prior to continuous infusion of malignant tumors of the uterine cervix and vagina. A preliminary report.
    ZEIT PR; HUGHES CR; CAHILL JJ; HAMILTON JG
    Cleve Clin Q; 1960 Jul; 27():119-24. PubMed ID: 13788112
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of malignant hemoblastoses and neoplasms with Endoxan].
    KUEHBOECK J; REIMER EE; STOIBER T
    Arzneimittelforschung; 1961 Mar; 11():196-9. PubMed ID: 13754857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with endoxan in the treatment of maligant tumors].
    KIRSCHKE W
    Chirurg; 1961 Aug; 32():372-5. PubMed ID: 13756301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of portio erosion under cytological and colposcopic control].
    SEIDLER M; BIENIASZ A; STASZKIEWICZ E; MINOL E; TOMASZEWSKI M
    Munch Med Wochenschr; 1962 Jan; 104():86-8. PubMed ID: 13910303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytological and histological study of the stratified squamous epithelium of the portio uteri located in direct proximity to cervical erosions].
    Aleksieva A
    Akush Ginekol (Sofiia); 1979; 18(6):433-7. PubMed ID: 525721
    [No Abstract]   [Full Text] [Related]  

  • 10. [1st clinical results of trials with cyclophosphamide (Endoxan) against malignant tumors].
    GARY-BOBO J; POURQUIER H; BELOTTE J
    Gaz Med Fr; 1962 Feb; 69():677-80. PubMed ID: 13897125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endoxan treatment of malignant tumors in otorhinolarygology].
    LOZERON H; LERUDULIER JL
    Praxis; 1961 Mar; 50():220-3. PubMed ID: 13763902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research with endoxan therapy of tumors in children].
    KOETTGEN U; WOLF M
    Med Klin; 1961 Jan; 56():15-8. PubMed ID: 15445395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mitomen and endoxan: prophylactic and palliative treatment in connection with cancer surgery].
    SORENSEN B
    Ugeskr Laeger; 1959 Aug; 121():1241-6. PubMed ID: 13832874
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endoxan pretreatment in apparently inoperable ovarian carcinoma?].
    REICH E
    Geburtshilfe Frauenheilkd; 1962 Mar; 22():271-8. PubMed ID: 14491131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of diagnosis and therapy of increased atypical squamous epithelium of the portio vaginalis uteri (H 3, so-called carcinoma in situ). II. Economical reflections on the therapy of H 3 and on the prevention of uterine cervix carcinoma].
    Moltz L; Kaiser P; Buchmann E
    Dtsch Gesundheitsw; 1970 Dec; 25(49):2319-24. PubMed ID: 5509406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bilateral neoplasms of the orbit with lymphatic type elements treated with antimitotic agents (Endoxan)].
    BERTONCINI G; PARDUCCI F
    Ann Ottalmol Clin Ocul; 1961 Dec; 87():763-74. PubMed ID: 13868478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of metastases of carcinoma of the testis with endoxan].
    GALLE P
    Klin Med Osterr Z Wiss Prakt Med; 1961 Sep; 16():446-8. PubMed ID: 13896417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the serum protein picture in metastasizing ovarian carcinoma under the influence of cytostatic therapy (endoxan)].
    MURKEN J
    Z Geburtshilfe Gynakol; 1962 Jul; 159():90-8. PubMed ID: 14477377
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aspecific pelvic immunotherapy with BCG injected into the portio uteri of women with uterine cancer].
    Cappello F; Dall'Alba B
    Minerva Ginecol; 1985; 37(1-2):31-6. PubMed ID: 4011026
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the cyclic nitrogen mustard phosphamide ester, Endoxan in the treatment of malignant tumors].
    SCHARENBERG P; KAPISCHKE F
    Munch Med Wochenschr; 1962 Jan; 104():134-8. PubMed ID: 14498052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.